Slate Star Codex

The FDA is Partly to Blame for Mylan’s EpiPen Price Gouging

The new head of the Food and Drug Administration (FDA) selected by President Barack Obama has very close ties to the pharmaceutical industry.
Dr. Robert Califf, an FDA deputy commissioner and cardiologist at Duke University, has had considerable dealings, including financial ones, with drug manufacturers, whose products must be approved by the agency he’s been tabbed to lead.